Upload
others
View
2
Download
0
Embed Size (px)
Citation preview
Molecular Characterisation of Petroleum M. Ahmed,1 S. Gong,1 D. Fuentes,1 S. Sestak,1 F. Theobald,2 and K. D’Silva3;1CSIRO Earth Science and Resource Engineering, North Ryde, Australia2Environmental Consulting, Cologne, Germany3Thermo Fisher Scientific, Bremen, Germany
Ap
plica
tion
No
te 3
02
63
Key WordsAnalysis of aliphatic, aromatic and branched/cyclic hydrocarbon fractions, Thermo Scientific DFS High Resolution Mass Spectrometer
IntroductionComprehensive molecular characterisation of petroleum is used to solve issues related to exploration and production of oil and gas. It can help identify processes that occurred in reservoirs and along migration pathways. It provides the ability to understand the key geological information encoded in the geochemistry of gas and liquid hydrocarbons and can help oil companies deduce the origin and maturity of petroleum hydrocarbons (natural gas, coal seam gas or oils). Geochemical fossils or biological markers, popularly called biomarkers, frequently convey genetic information about the types of organisms contributing to the organic matter of sediments. They are used for correlations (oil-oil and oil-source rock), for reconstitution of depositional environments, and also as indicators for diagenesis and catagenesis.1
CSIRO Organic Geochemistry Team is a world leading provider of research services to the petroleum industries and state and federal agencies.
Located in Sydney Australia, CSIRO Organic Geochemistry Team have conducted genetic characterisation of oils, fluid inclusion oils, natural gases and potential source rock extracts for various research projects on behalf of international energy companies including Chevron, PETRONAS, Woodside, Oil Search, Exxon-Mobil, Petrobras, Interoil, Origin Energy, Roc Oil, and BP Exploration & Production Inc.
CSIRO Organic Geochemistry Team currently use a Thermo Scientific™ DFS™ high resolution GC-MS for the molecular analyses of sedimentary organic matter, e.g., crude oils, fluid inclusion oils, condensates, potential source rock extracts, solid bitumen, pyrolyzates of ashpaltene/kerogen, etc. The DFS instrument provides a range of capabilities required for this application, including; high resolution, full scan, selected ion monitoring (also known as multiple ion detection, MID) and multiple reaction monitoring (MRM) with stable and predictable metastable product ion formation. All of these capabilities are combined by CSIRO for comprehensive analyses of petroleum hydrocarbons.
2 This application note presents a brief description of the methods and chromatographic conditions, using the DFS high resolution GC-MS for the analyses of:
• Aliphatic and aromatic hydrocarbon fractions of the North Sea Oil-1, a geochemical standard sample from the Norwegian Petroleum Directorate
• Branched /cyclic hydrocarbon fraction of a standard mixture of oils called AGSO STD obtained from Geoscience Australia (formerly, the Australian Geological Survey Organization)
Results of these analyses for the identification/quantification of some selected hydrocarbon biomarkers are presented in the following section.
Methods
Gas Chromatographic Methods
GC Thermo Scientific Trace Ultra™ GC
Sampler Thermo Scientific TriPlus XT™
Carrier gas Helium
Carrier gas flow rate Constant (1.5 mL/min)
Injector Split/Splitless
Injection temperature 260°C
Injection volume 1 µL
Sample concentration 100 - 500 µg/mL in dichloromethane
GC column equivalent TraceGOLD™ TG-1MS 60 m × 0.25 mm, 0.25 µm film P/N 26099-1540 and
TraceGOLD TG-5MS 60 m × 0.25 mm, 0.25 µm film P/N 26098-1540
Temperature programs A) 40 °C ( 2 min) @ 4 °C min-1 to 310 °C (40 min)
B) 40 °C (2 min) @ 20 °C min-1 to 200 °C (0 min) 2 °C min-1 to 310 °C (40 min)
Mass Spectrometer Parameters
MS Thermo Scientific DFS
Electron energy 70 eV
Resolution 1000 at 5% peak height
Injection temperature 260 °C
Transfer line temperature 280 °C
Source temperature 280 °C
Mass Spectrometer Data Acquisition Methods
Full scan of analysis of aliphatic and m/z 50-550, scan rate 0.5 sdec-1. aromatic hydrocarbons GC program A.
Multiple ion detection (MID) analysis m/z 128, 134, 142, 154, 156, 166, of aromatic hydrocarbon fraction, 168, 170, 178, 183. GC program A. Method-A
Multiple ion detection (MID) analysis m/z 178, 180, 182, 183, 184.03, of aromatic hydrocarbon fraction, 184.12, 192, 197, 198.05, 198.14, Method-B 202, 206, 212, 216, 220, 234. GC program A.
Multiple ion detection (MID) analysis m/z 177, 183, 191, 205, 217,218, of aliphatic hydrocarbon or its 231.11, 231.21,253, 259. GC program B. branched chain and cyclic fraction
Multiple Reaction Monitoring (MRM) m/z 370>191, 384>191, 398>191, analysis for hopanes 412>191, 426>191, 440>191, 454>191, 468>191, 482>191. GC program B.
Multiple Reaction Monitoring m/z 358>217, 372>217, 386>217, (MRM) analysis for steranes 400>217, 414>217, 414>231. GC program B.
ResultsCrude oils and source rock extracts are complex mixtures of many classes of compounds including source and maturity related biomarkers such as n-alkanes, isoprenoids, terpanes, steranes and diasteranes. Some biomarkers are often present in very low concentrations requiring different modes of GC-MS analyses for their identification and/or quantification; full scan, multiple ion detection and multiple reaction monitoring (MRM).
Full scan analyses provide mass spectra for structural elucidation and chromatograms of all ions. Multiple ion detection (MID) methods acquire only selected ions, e.g., m/z 123, 191, 217, etc. and provide results of better sensitivity than full scan, providing information about trace components. This method can be used to determine the fingerprints for the selected compound types (e.g., bicyclic sesquiterpanes, hopanes, steranes and diasteranes). Multiple reaction monitoring analyses monitor a selected daughter ion (e.g., m/z 217) formed from molecular ions that decompose in the first field-free region of a double-focussing mass spectrometer. This method provides the necessary selectivity required to analyze these specific compounds in such a complex matrix; resulting in better sensitivity and signal-to-noise ratios.
3Full Scan Analyses
Figure 1. Full scan (a) Total ion chromatogram and (b) m/z 85 extracted ion chromatogram of the aliphatic hydrocarbon fraction showing the distributions of n-alkanes and isoprenoids. Pr = Pristane, Ph = Phytane.
n ‐C 14
Squalane
Contaminant NL:2.25E9TIC MS NSO1_ALI_01A_M
RT: 0.00 - 99.01
24
26 32.8736.0629.49 39 08
[a]Squalane (IS)
14
16
18
20
22
24
Abu
ndan
ce
29.49 39.0825.91
47.2522.11 63.4749.72
52.0818.14
n ‐C 8 n ‐C
Pr
Ph
2
4
6
8
10
12
Rela
tive
67.9069.56
14.1073.26
75.5081.22 84.898.08 89.29
7.980 14
RT: 0.00 - 99.01
10032.87
36.06
NL:7.92E7
m/z= 84.60-85.60 MS
NSO1_ALI _01A_M
n ‐C 14
0 10 20 30 40 50 60 70 80 90Time (min)
00.14
[b]
50
60
70
80
90
bund
ance
29.4939.08 41.95
25.91
47.25
22.1149.72
Squalane (IS)
[b]
10
20
30
40
50
Rela
tive A
b
52.0863.47
58.5918.14
14.1064.38
67.8910.3469.56
73 269 44
n ‐C 8
n ‐C 37
PrPh
0 10 20 30 40 50 60 70 80 90Time (min)
0
10 73 .269.44 75.51 81.21 89.287.99
37
4
C30 αβ
C29 αβ
C30*
RT: 20.00 - 82.00 SM: 5G
20 25 30 35 40 45 50 55 60 65 70 75 80 Time (min)
0
10
20
30
40
50
60
70
80
90
100
Rela
tive
Abun
danc
e
C31 αβ S
R S R
R R R
S
S S
Ts Tm
C29Ts
C30 βα
Gammacerane
C31 βα
C32 αβ C33 αβ
C34 αβ C35 αβ 19/3
20/3
21/3 23/3 24/3 25/3 24/4
26/3
C29*
MID Analyses
44.00 - 64.00 SM: 5G100
70
80
90
NL: 5.92E4m/z = 216.95 - 217.45 MSNSO1_110923_ALI_D
30
40
50
60
10
20
30
44 46 48 50 52 54 56 58 60 62 64Time (min)
RT:
Rela
tive
Abun
danc
e
20SC27βα
20RC27βα
20RC27αβ
20SC27αβ
20SC27ααα
20SC28αβ
20S*C28βα
20R*C28βα
20R + C βα 20S C27αββ
29
20S + C αβ 20R* C27αββ
28
20RC27ααα
20RC29βα
αβC29
20S
20RC28αββ
20SC28αββ
αααC28
20R
20SC29ααα
20RC29αββ
20SC29αββ
20RC29ααα
20SC30ααα
20SC30αββ
20RC30αββ
20RC30ααα
20S*C28ααα
Figure 3. MID mass chromatogram m/z 217 of the aliphatic hydrocarbon fraction showing C27
–C29
steranes and diasteranes. Peak assignments define stereochemistry at C-20 (S and R ); βα, αβ, ααα and αββ denote 13β(H),17α(H)-diasteranes, 13α(H),17β(H)-diasteranes, 5α(H),14α(H),17α(H)-steranes and 5α(H),14β(H),17β(H)-steranes, respectively. * = isomeric peaks (24S and 24R ).
Figure 2. MID mass chromatogram m/z 191 of the aliphatic hydrocarbon fraction showing the distribution of terpanes. Peak assignments define stereochemistry at C-22 (S and R ); αβ and βα denote 17α(H), 21β(H) -hopane and 17β(H), 21α(H)-moretane, respectively. 19/3 – 26/3 = C
19 – C
26 tricyclic terpanes, 24/4 = C
24
tetracyclic terpane, Ts = C27
18α(H), 22,29,30-trisnorneohopane, Tm = C27
17α(H), 22,29,30-trisnorhopane.
5
Figure 4. (a) m/z 170.11, (b) m/z 192.09, (c) m/z 206.11 and (d) m/z 234.14 mass chromatograms of the aromatic hydrocarbon fraction showing the distributions of C
3-alkylnaphthalenes, methylphenanthrenes, C
2-alkylphenanthrenes and retene, respectively. TMN = Trimethylnaphthalene, MP= Methylphenanthrene,
EP = Ethylphenanthrene, DMP = Dimethylphenanthrene.
RT: 36.8 - 39.8 SM:5G
70
80
90
100 NL: 1.41E6m/z = 169.61- 170.61 MSNSO1_ARO _24JUL_B
70
80
90
100[a]
1,3,7‐TMN
1,3,6‐TMN
1,3,5‐+ 1,4,6‐TMN2,3,6‐TMN
1,2,7‐TMN3 MP
2‐MP
9‐MP
1‐MP
20
30
40
50
60
20
30
40
50
601,6,7‐TMN
1,2,5‐TMN
1,2,4‐
1,2,6‐TMN
3‐MP
37.0 37.5 38.0 38.5 39.0 39.5Time (min)
0
10
20
47.0 47.5 48.0 48.5 49.0Time (min)
0
10
20
100 100
1,2,3‐TMNTMN
Retene1,3‐+ 3,9‐+ 3,10‐+ 2,10‐DMP
50
60
70
80
90
50
60
70
80
90
3,5‐+ 2,6‐DMP
2,7‐DMP
1,6‐+ 2,9‐+ 2,5‐DMP
1,7‐DMP
0
10
20
30
40
0
10
20
30
40
3‐EP
9‐+ 2‐+ 1‐EP +3,6‐DMP
, ,
2,3‐+ 1,9‐+ 4,9‐+ 4,10-DMP
1,8‐DMP1,2‐DMP
49.5 50.0 50.5 51.0 51.5 52.0 52.5Time (min)
52 53 54 55 56 57 58 59 60Time (min)
0
Rela
tive
Abun
danc
eRe
lativ
e Ab
unda
nce
[c] NL: 9.86E5m/z = 205.61- 206.61 MSNSO1_aro _24jul_c
RT: 49.50 - 52.50 SM:5G
[b] NL: 1.54E6m/z = 191.59 - 192.59 MSnso1_aro _24jul_C
RT: 47.00 - 49.00 SM:5G
Rela
tive
Abun
danc
e
NL: 9.86E5m/z = 205.61- 206.61 MSNSO1_aro _24jul_c
[d]
Rela
tive
Abun
danc
e
RT: 52.00 - 60.00 SM:5G
6
42.00 - 58.00 SM: 5GRT:
40
60
80
NL: 1.15E4
m/z= 215.70-232.70 F: + c
EI SRM ms2
[215.70-218.70] MS
AGSO 06AUG12 STER
XT
60
80
1000
20_ _
NL: 4.02E3
m/z= 215.70-232.70 F: + c
EI SRM ms2
[215 70 218 70] MSXT
XT
m/z 386 →217
80
1000
20
40.
AGSO_06AUG12_STER
NL: 9.22E3
m/z= 215.70-232.70 F: + c
EI SRM ms2
XTXT C28 Steranes and
diasteranes
100
0
20
40
[215.70-218.70] MS
AGSO_06AUG12_STER
NL: 8.80E2
20
40
60
80 m/z= 215.70-232.70 F: + c
EI SRM ms2
[215.70-218.70] MS
AGSO_06AUG12_STER
20Sm/z 414 → 217
C30 Steranes and diasteranes
42 44 46 48 50 52 54 56 58Time (min)
0
C30βα
20RC30βα
20SC30ααα
20RC30αββ
20SC30αββ
αααC30
20R
m/z 400 → 217
20SC29βα
C29 Steranes and diasteranes
R20C29αβ
20RC29βα
C29αβ20S
20RC29αββ
20SC29ααα 20RC29
ααα
20SC29αββ
20S*C28βα
20R*βαC28
S20C28αβ
20R*C28αβ
20S*C 28ααα 20R C28
αββ20SC28
αββ
m/z 372 → 217C27 Steranes and diasteranes
20RC27ααα
20SC27αββ
20RC27αββ20SC27
ααα
R20C27αβ
S20C27αβ20RC27
βα20SC27
βα
Rela
tive
Abun
danc
eRe
lativ
e Ab
unda
nce
Rela
tive
Abun
danc
eRe
lativ
e Ab
unda
nce
100
20RC28ααα
MRM Analyses
Figure 6. MRM chromatograms showing m/z M+>217 metastable transitions of C27
, C28
, C29
and C30
steranes and diasternaes. Peak assignments define stereochemistry at C-20 (S and R ); βα, αβ, ααα and αββ denote 13β(H),17α(H)-diasteranes, 13α(H),17β(H)-diasteranes, 5α(H),14α(H),17α(H)-steranes and 5α(H),14β(H),17β(H)-steranes, respectively. XT = cross talks, * = isomeric peaks (24S and 24R ).
RT: 50.00 - 80.00 SM: 5G
40
60
80
100 NL: 1.90E4
m/z= 189.70-192.70 F: + c EI SRM ms2 [email protected] [189.70-192.70] MS AGSO_25JUL_HOPS
m/z 370 →191C27 Hopanes
TsTm
Bicadinane T
Bicadinane T1
80
1000
20
40
NL: 1.08E4m/z = 189.70-192.70 F: + c EI SRM ms2 [email protected] [189.70-192.70] MS AGSO 25JUL HOPS
Bicadinane RC 27
XT
80
1000
20
40
_
NL: 4.32E4
m/z = 189.70-192.70 F: + c EI SRM ms2 398 40@cid0 00
28,3
0-BN
H
TNH
C 29 αβ
1000
20
40
60
.
[189.70-192.70] MS AGSO_25JUL_HOPS
NL: 3.97E4
C 29 Ts
C 29* C 29 25 ‐nor
C 30 αβ
XT
20
40
60
80m/z = 189.70-192.70 F: + c EI SRM ms2 [email protected] [189.70-192.70] MS AGSO_25JUL_HOPS
C
Oleanane±Lupane
C 30* C 30 30 ‐norGammacerane
50 55 60 65 70 75 80Time (min)
0
20
40
60
80
100 NL: 8.87E3TIC F: + c EI SRM ms2 [email protected] [189.70-192.70] MS AGSO_25JUL_HOPS
C 32SR
RT: 58.59 - 88.59 SM: 5G
40
60
80
100
ative
Abu
ndan
ce
NL: 1.53E4m/z= 189.70-192.70 F: + c EI SRM ms2 [email protected] [189.70-192.70] MS AGSO_25JUL_HOPS
C 31S
R
020
Rel C 31
20
40
60
80
1000
20
NL: 4.49E3m/z= 189.70-192.70 F: + c EI SRM ms2 [email protected] [189.70-192.70] MS AGSO_25JUL_HOPS
C 33S
R
20
40
60
80
1000
0
NL: 2.08E3m/z= 189.70-192.70 F: + c EI SRM ms2 [email protected] [189.70-192.70] MS AGSO_25JUL_HOPS
C 34S
R
20
40
60
80
1000
NL: 1.69E3m/z= 189.70-192.70 F: + c EI SRM ms2 [email protected] [189.70-192.70] MS AGSO_25JUL_HOPS
C 35S
R
60 65 70 75 80 85Time (min)
0
29,3
0-BN
H
25,3
0-BN
H
β
60
Rela
tive
Abun
danc
eRe
lativ
e Ab
unda
nce
Rela
tive
Abun
danc
eRe
lativ
e Ab
unda
nce Re
lativ
e Ab
unda
nce
Rela
tive
Abun
danc
e
αβ
αβ
_
αβ
αβ
Rela
tive
Abun
danc
eRe
lativ
e Ab
unda
nce
*
αβ
m/z 384 →191C28 Hopanes
m/z 398 →191C29 Hopanes
C29βα
m/z 412 →191C30 Hopanes
m/z 426 →191C31 Hopanes
m/z 440 →191C32 Hopanes
m/z 454 →191C33 Hopanes
C 32*
C 33*
m/z 468 →191C34 Hopanes
m/z 482 →191C35 Hopanes
Figure 5. MRM chromatograms showing m/z M+>191 metastable transitions of C27
, C28
, C29
, C30
, C31
, C32
, C33
, C34
and C35
hopanes. XT = cross talk, BNH = Bisnorhopane, TNH = 17 α(H), 18 α(H), 21 β(H)-trisnorhopane.
Thermo Fisher Scientific Bremen, GmbH is ISO 9001:2008 Certified
AN30263_E 03/13S
Africa-Other +27 11 570 1840Australia +61 3 9757 4300Austria +43 1 333 50 34 0Belgium +32 53 73 42 41Canada +1 800 530 8447China +86 10 8419 3588Denmark +45 70 23 62 60
Europe-Other +43 1 333 50 34 0Finland/Norway/Sweden +46 8 556 468 00France +33 1 60 92 48 00Germany +49 6103 408 1014India +91 22 6742 9434Italy +39 02 950 591
Japan +81 45 453 9100Latin America +1 561 688 8700Middle East +43 1 333 50 34 0Netherlands +31 76 579 55 55New Zealand +64 9 980 6700Russia/CIS +43 1 333 50 34 0South Africa +27 11 570 1840
Spain +34 914 845 965Switzerland +41 61 716 77 00UK +44 1442 233555USA +1 800 532 4752
www.thermoscientific.com/DFS©2013 Thermo Fisher Scientific Inc. All rights reserved. ISO is a trademark of the International Standards Organization. All other trademarks are the property of Thermo Fisher Scientific Inc. and its subsidiaries. Specifications, terms and pricing are subject to change. Not all products are available in all countries. Please consult your local sales representative for details.
Ap
plica
tion
No
te 3
02
63
ConclusionsThe capabilities of the Thermo Scientific DFS high resolution mass spectrometer have enabled the continuation and development of oil biomarker research at CSIRO Organic Geochemistry Laboratories.
The results generated using the DFS instruments allow CSIRO to elucidate and quantify the molecular distribu-tions of the aliphatic and aromatic hydrocarbon biomarkers, such as, n-alkanes, regular isoprenoids, steranes and diasteranes, tri- and tetracyclic terpanes, hopanes, alkylnapthalenes, alkylphenanthrenes, retene, etc. (Figs 1 – 6). These results provide useful tools for the assessment of:
• Secondary alteration processes - biodegradation, evaporative fractionation, water washing
• Source or origin of organic matter - higher plants, algae, prokayriotic, eukaryotic
• Thermal maturity - immature, mature, over mature
• Palaeo-environmental condition - marine, deltaic, lacustrine, terrigeneous
• Lithology - clay rich, carbonates
• Geological age
• Oil-oil and/or oil-source correlations
Applications of such results in petroleum exploration geochemistry are described in numerous papers2–5 and also in CSIRO publications.6–9
AcknowledgementsWe would like to thank the team at CSIRO Sydney for the analysis of all samples and preparation of this application note.
References1. Tissot, B.P., Welte, D.H., 1984. Petroleum formation
and occurrence, pp. 699. Springer, Berlin.
2. Seifert, W.K., Moldowan, J.M., Jones, R.W., 1979. Applications of biological marker chemistry to petroleum exploration, 2, pp. 425-438. Heyden, London.
3. Mackenzie, A.S., 1984. Applications of biological markers in petroleum geochemistry. In: J.M. Brooks, D.H. Welte (Eds.), Advances in Petroleum Geochemistry 1 (Ed. by J.M. Brooks, D.H. Welte), pp. 115-212. Academic Press, London.
4. Peters, K.E., Walters, C., Moldowan, J.M., 2005. The Biomarker Guide, pp. 1155 pp. Cambridge University Press, Cambridge.
5. Alexander, R., Larcher, A.V., Kagi, R.I., Price, P.L., 1988. The use of plant derived biomarkers for correlation of oils with source rocks in the Cooper/Eromanga Basin System, Australia. APEA Journal, 28(1), 310-324.
6. George, S.C., Volk, H., Dutkiewicz, A., Ridley, J., Buick, R., 2008. Preservation of hydrocarbons and biomarkers in oil trapped inside fluid inclusions for >2 billion years. Geochimica et Cosmochimica Acta, 72, 844-870.
7. Gong, S., George, S.C., Volk, H., Liu, K., Peng, P., 2007. Petroleum charge history in the Lunnan Low Uplift, Tarim Basin, China - Evidence from oil-bearing fluid inclusions. Organic Geochemistry, 38, 1341-1355.
8. Volk, H., Kempton, R.H., Ahmed, M., Gong, S., George, S.C., Boreham, C.J., 2009. Tracking petroleum systems in the Perth Basin by integrating microscopic, molecular and isotopic information on petroleum fluid inclusions. Journal of Geochemical Exploration, 101, 109.
9. Ahmed, M., Volk, H., Allan, T., Holland, D., 2012. Origin of oils in the Eastern Papuan Basin, Papua New Guinea. Organic Geochemistry, 53, 137-152.